Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-16

FDA Approved: TIMOLOL MALEATE — Supplemental Application (First Nation Group, LLC)

View source ↗

Summary

The FDA approved a supplemental application for TIMOLOL MALEATE from First Nation Group, LLC, authorizing a new generic product on the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Timolol maleate (Timolol maleate)

Snippet

SUPPL AP for TIMOLOL MALEATE (TIMOLOL MALEATE)